Clinical Applications and Safety of Photobiomodulation
An evidence-based expert consensus reviewed the clinical use and safety of PBM across multiple applications, including dermatologic and skin-related settings.
Explore research examining visible red light and photobiomodulation in relation to skin appearance, surface-level responses and other skin-focused applications.
A randomized, sham-controlled trial evaluated 660 nm red light PBM in women aged 45–60 using different weekly treatment frequencies.
The study reported improvements in several facial skin rejuvenation measures following repeated red light PBM sessions.
The trial provides recent clinical evidence on visible red light under a defined 660 nm treatment protocol and highlights the role of treatment frequency.
An evidence-based expert consensus reviewed the clinical use and safety of PBM across multiple applications, including dermatologic and skin-related settings.
A randomized exploratory study evaluated combined yellow, red and infrared LED treatment for facial photoaging and skin-related outcomes.
A clinical study reported progressive changes in several visible skin-aging measures during repeated red light PBM use, with some effects persisting after treatment ended.
Was visible red light, near-infrared light or a combination used?
Consider irradiance, treatment time, treatment frequency and total exposure.
Studies may evaluate appearance, texture, hydration, elasticity or other skin-related measures.
Consider participant numbers, controls, follow-up periods and how outcomes were measured.
Skin-focused PBM studies may use different wavelengths, devices, treatment schedules, skin areas and outcome measures. Results from one study or protocol should not automatically be assumed to apply to every red light device or skin-focused application.
Research outcomes can vary depending on wavelength, irradiance, treatment duration, treatment frequency, device design, participant characteristics and study methodology.